Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway

The use of oral and transdermal HT was associated with an increased risk of BC. The associations varied according to HT type, individual drugs, molecular subtype, detection mode and BMI.